SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005462
Filing Date
2024-02-08
Accepted
2024-02-08 16:05:29
Documents
14
Period of Report
2024-02-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32703
  Complete submission text file 0001493152-24-005462.txt   210135

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE thar-20240208.xsd EX-101.SCH 3021
3 XBRL LABEL FILE thar-20240208_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE thar-20240208_pre.xml EX-101.PRE 22793
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3880
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 24608983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)